XBB.1.5 currently accounts for 90% of SARS-CoV-2 infections in the United States.
The CDC studied 9,100 people infected with COVID-19 in New York City during last November. [2022] until January this year [2023]
The hospitalization ratio among those infected with XBB.1.5 was 7.3% compared to 6.4% among those infected with the previously dominant strain of BQ.1.
The study also found no statistically significant difference in the percentage of
Deceased. The ratio is 0.8% for XBB.1.5 and 0.6% for BQ.1.
